Same Indication

Metformin vs Polatuzumab Vedotin

Metformin vs Polatuzumab Vedotin: Overview

This comparison examines the pharmacological differences between Metformin and Polatuzumab Vedotin.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Pharmacokinetics

Half-life: Metformin — 4-9 hours.

Chemical Properties

Molecular Formula: Metformin — C4H11N5.

Molecular Weight: Metformin — 129.1640 g/mol.

Type: Metformin — Small molecule; Polatuzumab Vedotin — Antibody drug conjugate.